Np mrd loader

Record Information
Version2.0
Created at2022-09-11 19:52:00 UTC
Updated at2022-09-11 19:52:00 UTC
NP-MRD IDNP0319036
Secondary Accession NumbersNone
Natural Product Identification
Common Namelevomethadyl acetate
DescriptionLevomethadyl Acetate, also known as LAAM or levacetylmethadolum, belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. It also acts as a potent, noncompetitive α3β4 neuronal nicotinic acetylcholine receptor antagonist. Unlike methadone, which requires daily administration, LAAM is administered two to three times a week. Levomethadyl Acetate is a drug which is used for the treatment and management of opiate dependence. It is sometimes used to treat severe pain in terminal patients. It has a melting point of 215 °C and a molecular weight of 353.50. Levomethadyl Acetate is a very strong basic compound (based on its pKa). Levomethadyl acetate can be converted into nor-levomethadyl acetate and formaldehyde through its interaction with the enzyme cytochrome P450 3A7. In humans, levomethadyl acetate is involved in levomethadyl acetate metabolism pathway. In 2001, LAAM was removed from the European market due to reports of life-threatening ventricular rhythm disorders. Levomethadyl Acetate is a potentially toxic compound. levomethadyl acetate is found in Apis cerana. levomethadyl acetate was first documented in 2000 (PMID: 11058673). LAAM is indicated as a second-line treatment for the treatment and management of opioid dependence if patients fail to respond to drugs like methadone or buprenorphine (PMID: 12220607) (PMID: 12646332) (PMID: 15104241) (PMID: 12676878).
Structure
Thumb
Synonyms
ValueSource
(-)-alpha-AcetylmethadolChEBI
(1S,4S)-4-(Dimethylamino)-1-ethyl-2,2-diphenylpentyl acetateChEBI
1-alpha-AcetylmethadolChEBI
LAAMChEBI
LevacetilmetadolChEBI
LevacetylmethadolumChEBI
LevomethadylChEBI
OrlaamChEBI
LevacetylmethadolKegg
(-)-a-AcetylmethadolGenerator
(-)-Α-acetylmethadolGenerator
(1S,4S)-4-(Dimethylamino)-1-ethyl-2,2-diphenylpentyl acetic acidGenerator
1-a-AcetylmethadolGenerator
1-Α-acetylmethadolGenerator
Levomethadyl acetic acidGenerator
Levo-alphacetylmethadolHMDB
Levo-methadyl acetateHMDB
Nor-laamHMDB
Levo-alpha-acetylmethadolHMDB
Levomethadyl acetate hydrochlorideHMDB
(3R,6R)-3-Acetoxy-6-dimethylamino-4,4-diphenylheptaneHMDB
DimepheptanolHMDB
6-(Dimethylamino)-4,4-diphenyl-3-heptanol acetateHMDB
AlphacetylmethadolHMDB
LevoacetylmethadolHMDB
MethadolHMDB
AcetylmethadolHMDB
AmidolacetateHMDB
AcemethadoneHMDB
Levo alpha acetylmethadolHMDB
Methadyl acetateHMDB
Chemical FormulaC23H31NO2
Average Mass353.4977 Da
Monoisotopic Mass353.23548 Da
IUPAC Name(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl acetate
Traditional Namelevomethadyl acetate
CAS Registry NumberNot Available
SMILES
CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
InChI Identifier
InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m0/s1
InChI KeyXBMIVRRWGCYBTQ-AVRDEDQJSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Apis ceranaLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassDiphenylmethanes
Direct ParentDiphenylmethanes
Alternative Parents
Substituents
  • Diphenylmethane
  • Aralkylamine
  • Amino acid or derivatives
  • Carboxylic acid ester
  • Tertiary aliphatic amine
  • Tertiary amine
  • Carboxylic acid derivative
  • Monocarboxylic acid or derivatives
  • Amine
  • Organooxygen compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Carbonyl group
  • Organic nitrogen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP4.78ALOGPS
logP4.88ChemAxon
logS-5.3ALOGPS
pKa (Strongest Basic)9.87ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area29.54 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity117.86 m³·mol⁻¹ChemAxon
Polarizability40.53 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
HMDB IDHMDB0015358
DrugBank IDDB01227
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID14401
KEGG Compound IDC08012
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkLevomethadyl_Acetate
METLIN IDNot Available
PubChem Compound15130
PDB IDNot Available
ChEBI ID6441
Good Scents IDNot Available
References
General References
  1. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE: A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000 Nov 2;343(18):1290-7. doi: 10.1056/NEJM200011023431802. [PubMed:11058673 ]
  2. Kreek MJ, Vocci FJ: History and current status of opioid maintenance treatments: blending conference session. J Subst Abuse Treat. 2002 Sep;23(2):93-105. doi: 10.1016/s0740-5472(02)00259-3. [PubMed:12220607 ]
  3. Kuo I, Brady J, Butler C, Schwartz R, Brooner R, Vlahov D, Strathdee SA: Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance. J Subst Abuse Treat. 2003 Jan;24(1):67-74. doi: 10.1016/s0740-5472(02)00343-4. [PubMed:12646332 ]
  4. Deshmukh SV, Nanovskaya TN, Hankins GD, Ahmed MS: N-demethylation of levo-alpha-acetylmethadol by human placental aromatase. Biochem Pharmacol. 2004 Mar 1;67(5):885-92. doi: 10.1016/j.bcp.2003.10.007. [PubMed:15104241 ]
  5. Nanovskaya TN, Deshmukh SV, Miles R, Burmaster S, Ahmed MS: Transfer of L-alpha-acetylmethadol (LAAM) and L-alpha-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule. J Pharmacol Exp Ther. 2003 Jul;306(1):205-12. doi: 10.1124/jpet.103.050690. Epub 2003 Apr 3. [PubMed:12676878 ]
  6. LOTUS database [Link]